In A First, FDA Requests An Opioid Be Pulled From The Market

In a dramatic first, the Food and Drug Administration is requesting that a manufacture, Endo Pharmaceuticals, remove a specific opioid drug, Opana ER, from the market because of its potential for causing abuse.

Read the full post at Forbes - Pharma & Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive